← Eichor
Study identifier: NCT06734520 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Clinical Study of Super Transplantation in the Treatment of Severe β-thalassemia

Condition: Thalassemia Majors (Beta-Thalassemia Major) · Haplo-identical Donors  ·  Sponsor: Guangzhou Women and Children's Medical Center

PhaseNA
Planned participants3
Who can joinAll sexes, 7 Years to 10 Years
Healthy volunteersNo

About this study

This is a single-arm, open label, phase 1 study in subjects with beta-thalassemia. This study will evaluate the safety and efficacy of preconditioning-free super-transplantation on beta-thalassemia pediatric patients.

This description comes directly from the study's public registry record.

Talk to the study team

Hua Jiang, Doctor  ·  86-020-38076501  ·  jiang_hua18@sina.cn

Always discuss trial participation with your own doctor first.

Locations (2)

Guangzhou Women and Children's Medical Center Affiliated to Guangzhou Medical UniversityGuangzhou, Guangdong, ChinaActive Not Recruiting
Guangzhou Women and Children's Medical Center Affiliated to Guangzhou Medical UniversityGuangzhou, Guangdong, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06734520